Haibin Deng

Haibin Deng

Auto-generated profile, based on publicly available information

Haibin Deng

Oncology Department, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, P. R. China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
ZZZhan Zheng
Zhan Zheng
YMYue Ma
Yue Ma
LWLifang Wang
Lifang Wang
HDHaibin Deng
Haibin Deng
ZWZhongqi Wang
Zhongqi Wang
ZXZhenye Xu
Zhenye Xu
Feiyanning (FYN), the Chinese herbal medicine (CHM), has been used to manage non-small cell lung cancer (NSCLC) for the past 23 years. Chemotherapeutic drugs can induce autophagy in cancer cells to protect themselves from death. However, FYN can inhibit the protective autophagy in cancer cells. We investigated the biological mechanisms on the synergistic effects of FYN combined with chemotherapy in lung cancer cells. We analyzed the effective chemical components for the quality control of FYN using the UPLC-Q-TOF-MS.The cell proliferation ability was detected by the cell counting kit-8 (CCK-8) and colony formation. The cell apoptosis was determined with Flow cytometry. Expression of important differential proteins were detected by western blot. Autophagy structure was observed by TEM (Tansmission electron microscopy). Tandem mCherry-EGFP-LC3B immunofluorescence was used to measure autophagic flux. Both FYN and cisplatin significantly induced apoptosis and inhibited cell proliferation in A549 cells. FYN reduced cell viability and increased apoptotic cell populations less effectively than cisplatin. FYN cooperated with cisplatin suppressed the cell viability, colony formation, as well as increased the cell apoptosis rate, and the expression of cleaved caspase-3 and PARP. FYN inhibited autophagy in A549 cells, which characterized by the decrease of autophagosome formation, lysosomal fusion, LC3B-II accumulation and SQSTM1 degradation, down-regulation of ATG5 and ATG7. Protective autophagy in A549 cells was induced by cisplatin. Suppression of the autophagic response using chloroquine (CQ) which is autophagy inhibitor improved the ability of cisplatin to kill cancer cells, as did FYN combined with cisplatin. In summary, we revealed that the synergistic mechanism of FYN and cisplatin is that FYN inhibited the protective autophagy induced by cisplatin in A549 cells.

29 January 2025 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
ZRZhijing Rao
Zhijing Rao
ZWZhongqi Wang
Zhongqi Wang
HDHaibin Deng
Haibin Deng
WSWan Su
Wan Su
XHXiaowei Huang
Xiaowei Huang
ZXZhenye Xu
Zhenye Xu

3 October 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
CZChengcheng Zhang
Chengcheng Zhang
JQJingru Qin
Jingru Qin
LYLu Yang
Lu Yang
ZZZhiyao Zhu
Zhiyao Zhu
JYJia Yang
Jia Yang
ZWZhongqi Wang
Zhongqi Wang
Osseous metastases of pulmonary carcinoma and the detailed mechanisms remain unclear, and the effects of exosomes (Exos) originated from pulmonary adenocarcinoma cells in this process have received a lot of attentions. Our study revealed that the Exos secreted from A549 cells (A549-Exos) enhanced osteoclastogenesis and osseous resorption in vitro. In addition, A549-Exos showed a targeted effect on bones to enhance osseous resorption in vivo. A549-exosomal miR-328 enhanced osseous resorption via downregulating neuropilin 2 (Nrp-2) expression, and A549-Exos miR-328 inhibitors suppressed osseous resorption in vivo. Therefore, A549-exosomal miR-328 enhances osteoclastogenesis via downregulating Nrp-2 expression, thus A549-Exos miR-328 inhibitors can be used as a potential nanodrug for treating osseous metastases.

9 July 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
CZChengcheng Zhang
Chengcheng Zhang
JQJingru Qin
Jingru Qin
LYLu Yang
Lu Yang
ZZZhiyao Zhu
Zhiyao Zhu
JYJia Yang
Jia Yang
WCWenlian Chen
Wenlian Chen
Bone metastasis of lung cancer and detailed mechanisms are still elusive, and the roles of exosomes derived from lung adenocarcinoma cells in this process have attracted much attention. In this study, we found that A549 cell-derived exosomes (A549-Exos) promoted osteogenesis and bone resorption in vitro. Furthermore, A549-Exos target bone in vivo and promoted bone resorption in vivo. Mechanistically, A549-Exosomal miR-328 promoted bone resorption by targeting Nrp2 and A549-Exos miR-328 Inhibitors inhibited bone resorption in vivo . Thus, A549-Exosomal miR-328 promote osteoclastogenesis by targeting Nrp2 and A549-Exos miR-328 Inhibitors may serve as a potential nanomedicine for the treatment of bone metastasis.